Abstract
With pharmaceutical companies increasingly looking for ways to extend the
revenue-earning lifetime of their biggest products, drug delivery has become
an important focus of the industry. Kalorama' s Drug Delivery Markets:
Implantable / Injectable and Needle-Free Delivery Systems provides detail for
business planners on the market for implantable / injectable delivery system
markets.
Biopharmaceutical products are driving growth of needle-free systems; there
will likely be significant increases in revenues in the vaccine arena. This
report looks at that trend and reports current and forecasted revenues for the
implantable/injectable drug delivery market, segmented into two main
categories:
- Needle-free drug delivery
- Other Injectable/Implantable
Kalorama' s unique analysis offers segmentation of this market for:
- Drug Delivery Techology Revenues
- Pharmaceuticals Sold via Delivery Technology
This breakout makes the report relevant to business plans of either device
technology companies or pharmaceutical concerns. (This market analysis does
not include drug-eluding stents or prefilled or regular syringes. Kalorama
considers these seperate markets)
The report covers both pharmaceuticals sold through implantable/injectable
delivery systems and the technologies themselves including:
- Detailed Profiles of Key Companies in Implantable/Injectable Delivery
- Brief Round-Up of Smaller Players
- Current Market Size and Forecasts to 2013
- Needle-Free Cost Savings, Protein-Coated Microcrystal Technology,
Nanotechnology, and Other Trends and Developments
- Revenue Forecasts
- New Products in Development
Kalorama' s trusted information-gathering process provides most accurate study
of the implantable/injectable delivery drug market available today.
Information and analysis presented in this report is based on extensive
interviews with senior management of top companies in the industry. While
major research literature and government information is culled, information is
corroborated and key market insights originate from interviews with industry
leaders.
Companies Profiled in the report include:
- Alkermes, Inc.
- ALZA Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc
- Nektar Therapeutics
- Pacira Pharmaceuticals, Inc.
- pSivida
- SurModics, Inc
- Zogenix Corporation
- AP Pharma
- Baxter BioPharma Solutions
- QLT USA, Inc
- Ypsomed Holding AG
| 
View Cart
